Cubist Systematic Strategies, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$353,000
-20.9%
15,159
-45.9%
0.02%
-30.8%
Q1 2018$446,000
-37.1%
28,016
-17.8%
0.03%
-31.6%
Q4 2017$709,000
-11.8%
34,094
-39.2%
0.04%
-15.6%
Q3 2017$804,000
+7940.0%
56,119
+9253.2%
0.04%
+4400.0%
Q2 2017$10,000
-98.3%
600
-98.9%
0.00%
-97.7%
Q1 2017$605,000
-49.1%
54,812
-33.0%
0.04%
-54.7%
Q4 2016$1,188,000
-50.4%
81,815
-16.1%
0.10%
-38.3%
Q3 2016$2,395,000
+2038.4%
97,556
+1651.8%
0.15%
+2100.0%
Q2 2016$112,000
-99.0%
5,569
-98.8%
0.01%
-99.0%
Q1 2016$11,746,000
+1.4%
446,606
+291.8%
0.67%
-1.0%
Q4 2015$11,588,000
+1.2%
113,998
+77.6%
0.68%
+17.1%
Q3 2015$11,453,000
+57.0%
64,206
+95.3%
0.58%
+62.2%
Q2 2015$7,297,000
+240.0%
32,871
+204.2%
0.36%
+240.0%
Q1 2015$2,146,000
+82.8%
10,805
+31.8%
0.10%
+66.7%
Q4 2014$1,174,000
+1098.0%
8,201
+955.5%
0.06%
+950.0%
Q2 2014$98,0007770.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders